We measured the manganese content of mononuclear blood cells and the manganese concentrations in whole blood and plasma from 31 healthy volunteers and 25 patients receiving total parenteral nutrition(TPN) (i.e., no dietary manganese). The manganese content (mean ± 2 SD) of mononuclear blood cells and the manganese concentration in whole blood and plasma in the healthy volunteers were 8.84 ± 4.18 ng/1 08 cells, 11.21 ± 4.68 gIL, and 1.21 ± 0.72 gIL, respectively. The manganese content of mononuclear blood cells from patients receiving TPN gradually decreased, falling below the lowest limit of the normal range by 21 weeks (95% confidence limits, 13-30 weeks) after starting TPN. Manganese concentrations in whole blood and plasma were within normal limits during our study period. These results suggest that the manganese content of mononuclear blood cells may better indicate manganese nutritional status than wholeblood or plasma concentrations.
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IndexingTerms: nutritional status/trace elements/metabolism
Manganese deficiency in animals produces growth disorders, alters skeletal and cartilage formation, and impairs reproduction (1). Manganese is therefore assumed to be an essential nutrient for humans, a!-though there are no convincing reports of manganese deficiency in humans. Attempts to deplete manganese experimentally in humans have met with mixed success (2, 3). One reason for this is that there is no proven method for assessing manganese nutritional status in humans.
The simplest and most common method used to assess manganese nutritional status is to measure its concentration in blood (4). Keen 
Materials and Methods Apparatus
For mononuclear blood cell counts, we used an automated blood cell counter (cc-108; Toua Iyou Denshi, Hyogo, Japan). We ashed the samples in a heating block (TPB-62; Advantec Toyo, Tokyo, Japan). These reagents were determined to be manganese-free by atomic absorption spectrophotometry.
Standards
were prepared by dilution of a 1000 mg/L reference solution, a certified atomic absorption standard (Wako Pure Chemicals, Osaka, Japan). All other chemicals used were guaranteed reagentgrade, obtained from Wako.
Subjects
We studied 25 patients supported by TPN and 31 healthy volunteersas controls. Their ages (mean ± SD) were 57.6 ± 14.9 years (range 35-81 years) and 29.8 ±
years (range 22-48 years), respectively.
The clinical features, including age, sex, the nature of the underlying disease, and duration of parenteral nutrition, are presented in Table 1 . None of the patients had oral intakes. The protocol of thisstudy was approved by the respectiveEthical Committees of Takeda Hospital and Roussel Morishita
Co. Blood was collected from an antecubital vein into a polyethylene syringe containing sodium heparin anticoagulant (final concentration: 15000 lU/L). Manganese was measured in whole blood and plasma and in mononuclear blood cells from all the subjects. We centrifuged 3 mL of whole blood at 1300g for 15 mm to obtain plasma. Centrifuge at 500g for 30 mm at 20#{176}C. Discard the supernatant fluid above the mononuclear blood cell layer. Then, collect the mononuclear blood cell layer and transfer it to a 15-mL polystyrene tube. Add 5 mL of PBS, centrifuge at 400g for 10 mm at 4#{176}C to pellet the mononuclear blood cells, and discard the supernate. Wash the pellet three times in PBS to remove platelets (centrifuge each time at 400g for 10 min at 20#{176}C). Finally, resuspend the mononuclear blood cell pellet in 1.1 mL of PBS, and transfer exactly 1 mL to a 1.5-mL polypropylene tube. In healthy volunteers, the composition ratio (mean ± SD, n = 5) of lymphocytes, monocytes, platelets, granulocytes, and erythrocytes in this suspension was 83% ± 3%, 12% ± 1%, <0.5%, 2% ± 1%, and 3% ± 2%, respectively [differential cell count obtained by the Wright-Giemsa stain method (7) The mononuclear blood cell pellet in the 1.5-mL polypropylene tube was dissolved by adding 100 pi of 13 molJL HNO3 and heating each sample and tube in a heating block at 75#{176}C for 90 mm. We then measured the volume of the solution, using a calibrated glass capillary pipette. Whole blood (0.5 mL) and plasma (1.0 mL) were digested with 3 and 2.5 mL of 13 mol/L HNO3, respectively; each sample tube was then placed in a heating block at 85#{176}C for 28 h, after which the sample volumes were measured.
The manganese concentrations in the samples were determined by atomic absorption spectrophotometry with graphite furnace and deuterium arc background correction.
The Fig. 1, A and B) . These concentrations are similar to recentlyreportedvalues (2, 3, 8) . The plasma manganese concentration in TPN patients was comparable to that in volunteers, regardless of the period of TPN treatment (there was no statistical relation between TPN duration and plasma manganese concentration; the regression slope was not significantly different from zero). The relation between whole-blood manganese concentration (y) of TPN patients and duration of TPN (x) was statistically significant (Fig. 1B, top) Duration of TPN, weeks regression equation was y = 11.110 -0.152x (slope significantly different from zero, P <0.01). However, we discarded the significant regression for whole blood since all of the values fell within the reference interval.
Results and Discussion
The manganese content we measured in the mononuclear blood cells of the healthy volunteers was 8.84 ± 4.18 ng/108 cells (range 5.60-13.27 ng/108 cells) (Fig.  1C) Table 1 ). Area Fig. 1,A-C) , the downward withinperson trends were explored with repeated measures of analysis of variance. Consequently, the results were statistically significant (P <0.05) in mononuclear blood cells alone (Fig. 1C) biliary excretion (14) . In TPN patients, the former of these homeostatic mechanisms is bypassed. If TPN patients have cholecystitis, the latter mechanism is also impaired.
Consequently, manganese nutritional status may not fall, and our results may indicate this. In the present study,the age ranges differed between healthy volunteers and TPN patients, but this difference did not influence our results. The manganese content of various tissues is fairly similar in most animal species and is relatively constant with age (1, 15) ; moreover, our results indicate no significant regression relation between age and manganese in mononuclear blood cells, whole blood, or plasma (slopes not significantly different from zero for each regression).
We conclude that the manganese content of mononuclearblood cells is a useful indicator of manganese nutritional status. Further studies in humans, e.g., assay of mononuclear blood cell and tissue manganese contents in subjects with differences in manganese intake and (or) metabolism, and assessment of the influence of TPN duration or diseases on the differences for the isolated cells, are necessary to confirm this.
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